Advagene Biopharma Co., Ltd. (TPEX:6709)
25.40
-0.15 (-0.59%)
May 8, 2026, 1:44 PM CST
42.70% (1Y)
| Market Cap | 1.51B +33.0% |
| Revenue (ttm) | n/a |
| Net Income | -68.29M |
| EPS | -1.15 |
| Shares Out | 59.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 115,000 |
| Average Volume | 74,658 |
| Open | 25.40 |
| Previous Close | 25.55 |
| Day's Range | 25.30 - 25.70 |
| 52-Week Range | 16.65 - 41.00 |
| Beta | 0.68 |
| RSI | 35.00 |
| Earnings Date | May 14, 2026 |